Skip to main content
SANA
NASDAQ Life Sciences

Sana's Diabetes Cell Therapy Shows Durable Function at 14 Months, NEJM Publishes Follow-Up

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.73
Mkt Cap
$1.071B
52W Low
$2.61
52W High
$6.55
52W Position info
43% above low
Off High info
43% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

SANA sits 43% above its 52-week low of $2.61.

Summary

Sana's hypoimmune-modified islet cells continue to produce insulin without immunosuppression at 14 months in a type 1 diabetes patient, with new data published in NEJM. C-peptide levels rebounded at month 14 after a dip, and PET-MRI confirms cell survival. The company now expects to file an IND and start a Phase 1/2 trial for SC451 as early as this year, accelerating the path to a potential functional cure. This follows a going-concern warning and recent ATM equity raises, making the clinical progress critical for the company's outlook. The NEJM publication adds significant validation to the platform.

At the time of this announcement, SANA was trading at $3.73 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $2.61 to $6.55. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SANA - Latest Insights

SANA
Nov 05, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.44
Real-time Price: $2.40 info
Change: -$0.040 (-2%) info
Market Cap: $710.135M info
SANA
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.41
Real-time Price: $2.40 info
Change: -$0.010 (-0.41%) info
Market Cap: $710.135M info
SANA
Sep 08, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.85
Real-time Price: $2.40 info
Change: -$1.45 (-38%) info
Market Cap: $710.135M info
SANA
Aug 10, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.53
Real-time Price: $2.40 info
Change: -$1.13 (-32%) info
Market Cap: $710.135M info
SANA
Aug 10, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.53
Real-time Price: $2.40 info
Change: -$1.13 (-32%) info
Market Cap: $710.135M info